David Blum, MD, was named VP of medical affairs and clinical research for BioDelivery Sciences International (BDSI; Morrisville, North Carolina), effective Sept. 4. Blum joins BDSI from GlaxoSmithKline, where he was the medical director in its neuroscience medical development department. BDSI is a specialty pharmaceutical company that is focused on developing products to treat acute conditions such as pain.